5Selvais PL,Donckier JE.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure:influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation[J].Eur J Clin Invest,1998,28(8):636.
6Xie CW.The effect of atriopeptin on the aterial blood pressure in spontaneous hypertensive rats(SHR)[J].Fed Proc,1985,44(11):49.
77]Yamanaka M.Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor[J].Nature,1984,309(10):719.
8Holtwick R,Cotthardt M,Skryabin B,et al,Smooth muscle selective eletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure[J].Proc Natl Acad Sci USA,2002,99(70):7142.
2Bonow RO.New insights into the cardiac natriuretic peptides[J].Circulation,1996,93(11):1946-1950.
3Valli N,Gobinet A,Bordenave L.Review of 10 years of the clinical use of brain natriuretic peptide in cardiology[J].J Lab Clin Med,1999,134(5):437-444.
5Sata N,Tanaka Y, Suzuki S,et al.Effectiveness of angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker on atrial natriuretic peptide[J].Circ J,2003,67(12):1053-1058.
6Bianciotti LG,De Bold AJ.Effect of ET(A) receptor blockade on natriuretic peptide gene experession in DOCA2 salt hypertension[J].Am J Physiol,2000,279(1):93.
7Vasely DL,Chiou S,Douglass MA,et al.Atrial natriuretic peptide negatively and positively modulate circulating endothelin in humans[J].Metabolism,1996,45(3):315.
8Hilal-Dandan R,Ranzirez MT,Villegas S,et al.Endothelin ETA receptor regulates signaling and ANP gene expression via multiple G protein-2-linked pathways[J].Am J Physiol,1997,272(1 pt 2):130-137.
9Murohara T,Kugiyama K,Yasue H,et al.Interaction of nitrovasodilators,atrial natriuretic peptide and endothelium-derived nitricoxide[J].J Vasc Res,1996,33(1):78-85.
10Osta MD,Bosc LV,Majowicz MP,et al.Atrial natriuretic peptide modifies arterial blood pressure through nitricoxide pathway in rats[J].Hypertension,2000,35(5):1119-1123.
8GRAUSLUND J, NYBO M, GREEN A, et al. N-ter- minal pro brain natriuretic peptide reflects long-term com- plications in type 1 diabetes [ J ]. Scand J Clin Lab In- vest, 2010, 70 (6): 392-398.
9LIU C, AGN~S G, CORCUFF J B, et al. B-type natri- uretic peptide in type 2 diabetes mellitus: the influence of chronic renal failure and food [ J ]. Diabetes Care, 2005, 28 (3) : 752.
10MCKENNA K, SMITH D, MOORE K, et al. Brain na- triuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in type 1 diabetes mellitus [ J ]. Diabet Med, 2001, 18 (12): 973-978.
